Humacyte Free Cash Flow Per Share vs Price To Sales Ratio Analysis
| HUMAW Stock | USD 1.95 0.10 5.41% |
Humacyte financial indicator trend analysis is much more than just examining Humacyte latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Humacyte is a good investment. Please check the relationship between Humacyte Free Cash Flow Per Share and its Price To Sales Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.
Free Cash Flow Per Share vs Price To Sales Ratio
Free Cash Flow Per Share vs Price To Sales Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Humacyte Free Cash Flow Per Share account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong relationship.
The correlation between Humacyte's Free Cash Flow Per Share and Price To Sales Ratio is 0.73. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Humacyte, assuming nothing else is changed. The correlation between historical values of Humacyte's Free Cash Flow Per Share and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Humacyte are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Free Cash Flow Per Share i.e., Humacyte's Free Cash Flow Per Share and Price To Sales Ratio go up and down completely randomly.
Correlation Coefficient | 0.73 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Price To Sales Ratio
Price to Sales Ratio is figured by comparing Humacyte stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Humacyte sales, a figure that is much harder to manipulate than other Humacyte multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Most indicators from Humacyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Humacyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.Enterprise Value is likely to climb to about 284.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 21.1 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 4.3M | 6.2M | 1.1M | 1.1M | Depreciation And Amortization | 8.3M | 8.3M | 7.7M | 8.7M |
Humacyte fundamental ratios Correlations
Click cells to compare fundamentals
Humacyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Humacyte Stock Analysis
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.